PIK3CG and cancer: Experimental evidence obtained by manipulation of PI3K signalling in NSCLC cells also indicated that p110α is required for in vitro and in vivo growth and disclosed a network of PI3K-regulated transcription factors that may be responsible for the oncogenic effects exerted by aberrant PI3K signalling in cancer [48].